OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Michael Kuchenreuther, PhD, is a research analyst, at Numerof & Associates, Inc.
April 29, 2016
Immuno-oncology drugs are demonstrating patient benefits, but growing resistance to the high cost has implications for patients, market access, and manufacturers.
December 02, 2015
The author provides an overview of the key aspects of the current Canadian pharmaceutical market.
October 26, 2015
The authors look at key factors driving the risk-sharing agreements that have been implemented to reduce drug expenditures across Europe.
August 01, 2015
China’s emergence as a significant commercial market is forcing manufacturers to re-evaluate their overall business model.